# A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration

> **NCT02314299** · PHASE1,PHASE2 · COMPLETED · sponsor: **Stealth BioTherapeutics Inc.** · enrollment: 20 (actual)

## Conditions studied

- Diabetic Macular Edema
- Age-related Macular Degeneration

## Interventions

- **DRUG:** MTP-131

## Key facts

- **NCT ID:** NCT02314299
- **Lead sponsor:** Stealth BioTherapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02314299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02314299, "A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02314299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*